Core Insights - U.S. Physical Therapy, Inc. presented at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026, highlighting its role as a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services [1][1][1] Company Overview - Founded in 1990, U.S. Physical Therapy operates 783 outpatient physical therapy clinics across 44 states, offering preventative and post-operative care for orthopedic and sports-related injuries, as well as treatment for neurological injuries and rehabilitation for injured workers [1][1][1] - The company also provides industrial injury prevention services, including onsite injury prevention, rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments [1][1][1] Financial Highlights - For the year ended December 31, 2025, U.S. Physical Therapy reported an Adjusted EBITDA of $95.0 million, indicating a strong financial performance compared to the previous year [1][1][1] - The company announced the acquisition of an industrial injury prevention business for approximately $15.1 million, which currently generates about $7.0 million in annual revenues [1][1][1]

Core Viewpoint - U.S. Physical Therapy (USPH) shows potential for significant upside, with a mean price target of $105.33 indicating a 26.5% increase from its current price of $83.25 [1] Price Targets - The average price target consists of six estimates ranging from a low of $98.00 to a high of $113.00, with a standard deviation of $5.92, suggesting a consensus among analysts [2] - The lowest estimate indicates a 17.7% increase, while the highest suggests a 35.7% upside [2] Analyst Sentiment - Analysts are increasingly optimistic about USPH's earnings prospects, as indicated by a positive trend in earnings estimate revisions [4][11] - The Zacks Consensus Estimate for the current year has risen by 2.4% over the past month, with two estimates increasing and no negative revisions [12] Zacks Rank - USPH holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are a common metric, relying solely on them for investment decisions may not be prudent due to potential biases among analysts [3][10] - A low standard deviation in price targets indicates a high degree of agreement among analysts, which can be a starting point for further research [9]

Clinic Operations - The company owned and/or managed 780 clinics across 44 states as of December 31, 2025, with a significant concentration in Texas, Tennessee, and Michigan[28] - The company completed 49 clinic additions in 2025, while closing or selling 30 clinics, resulting in a net increase in clinic count[31] - The company’s clinics primarily charge on a per-procedure basis, with revenue sources including managed care programs, Medicare/Medicaid, and workers' compensation insurance[40] - Approximately 40.1% of visits and 35.8% of net patient revenue were from patients with Medicare or Medicaid coverage in 2025[44] - The company operates through two reportable business segments: physical therapy and industrial injury prevention services (IIP), with IIP services primarily contracted by Fortune 500 companies[210] Financial Performance - Total net patient revenue for the year ended December 31, 2025, was $650.4 million, representing a 15.9% increase from $560.6 million in 2024[42] - Managed care programs and commercial health insurance accounted for 48.5% of net patient revenue in 2025, while Medicare/Medicaid contributed 35.8%[42] - For the year ended December 31, 2025, net patient revenues from Medicare were approximately $213.5 million, an increase from $183.4 million in 2024, representing a growth of about 16.1%[113] - Approximately 64.2% of the company's revenues in 2025 were derived from private payors, while 35.8% came from Medicare and Medicaid[119] - The company declared dividends of $0.45 per share on four occasions in 2025, totaling an aggregate amount of $27,362 thousand[199] Acquisitions and Growth Strategy - The company has a strategy to continue acquiring outpatient physical therapy practices and expand its industrial injury prevention services sector[21] - The company has completed multiple acquisitions, including a 100% acquisition of an IIP business and a 55% equity interest in an ergonomics software business in October 2023[18] - The company acquired 100% of an additional industrial injury prevention (IIP) business on October 31, 2023, increasing ownership in Briotix Health to approximately 92%[59] - The company completed multiple acquisitions of outpatient physical therapy practices and IIP businesses, including a 60% interest in three clinics acquired in July 2025[212] - The company acquired a 40% interest in an outpatient home care practice on April 30, 2025, through its 50% owned subsidiary MSO Metro LLC[212] Regulatory Compliance - The company believes it is in compliance with applicable laws and regulations, but acknowledges the potential for future government review and interpretation[55] - The company is subject to various governmental inspections, reviews, audits, and investigations to verify compliance with Medicare and Medicaid programs[84] - The company has a Compliance Program in place to ensure adherence to federal and state laws and regulations related to healthcare[88] - The Compliance Committee, consisting of independent directors, oversees compliance with legal and regulatory requirements[91] - An adverse inspection or audit could result in penalties, including refunding payments, fines, or exclusion from Medicare and Medicaid programs[84] Workforce and Talent Management - As of December 31, 2025, the company employed approximately 7,294 people nationwide, including about 4,200 full-time employees[104] - The company provides management and administrative services to therapist-owned outpatient physical therapy practices, which employ an additional 801 individuals, with 453 being full-time[104] - The company emphasizes attracting and retaining top talent by fostering a diverse and healthy workplace, offering continuing education, skill development, and competitive compensation[104] - The operational leadership teams maintain long-standing relationships with local and regional universities to ensure a talent pipeline[104] - The company's clinical professionals are all licensed, with a significant majority holding advanced degrees[104] Risks and Challenges - The company is subject to risks associated with public health crises, which could disrupt operations and impact patient appointment scheduling[125] - The company may face challenges in obtaining additional financing due to outstanding debt obligations and market conditions[133] - The company is exposed to interest rate risks due to variable-rate borrowing, which could affect financial performance[136] - Labor costs are expected to rise due to competitive pressures in hiring qualified healthcare personnel, which may adversely affect profitability[160] - The company relies heavily on referrals from physicians, and any deterioration in these relationships could lead to a decline in net operating revenues[156] Cybersecurity and Technology - The company is vulnerable to cyber-attacks that could compromise sensitive patient information, leading to legal and reputational harm[153] - The Compliance Committee of the Board oversees cybersecurity risks and is composed of members with diverse expertise, including risk management and technology[185] - The Chief Information Systems Officer (CISO) is responsible for assessing and managing cybersecurity risks, with over 25 years of experience in IT and cybersecurity[187] - The company has integrated cybersecurity risk management into its broader risk management framework to promote a culture of cybersecurity awareness[179] Market Conditions and Economic Factors - The aging population is expected to increase demand for rehabilitation services, as this demographic has a higher incidence of disability[65] - The company anticipates continued efforts from federal and state governments to contain Medicaid expenditures, which could adversely affect revenue and profitability[126] - Increased post-payment reviews of claims submitted to Medicare may lead to additional costs and potential repayments of overpaid amounts[127] - Severe weather conditions can negatively impact clinic operations and lead to fluctuations in net operating revenues[163] Shareholder Considerations - The company has reserved approximately 315,221 shares for future equity grants as of December 31, 2025, which may lead to dilution for existing shareholders[174] - The common stock has traded on the NYSE since August 14, 2012, and began trading on NYSE TX under the symbol "USPH" effective May 28, 2025[197] - The company is currently restricted from paying dividends on common stock in excess of $50 million in any fiscal year under its Credit Agreement[199]

Financial Data and Key Metrics Changes - For the year ending 2025, adjusted EBITDA increased by $13.2 million, representing a 16.2% improvement over the prior year [4] - Net revenue increased by 16.3%, with physical therapy operations growing by 16% and injury prevention businesses by 18% [4] - Operating income improved by 18.4% [4] - Adjusted EBITDA for Q4 2025 was $24.8 million, up from $21.8 million in Q4 2024, marking a $3 million increase [17] - Full-year adjusted EBITDA increased by 16.1% from $81.8 million in 2024 to $95 million in 2025 [22] Business Line Data and Key Metrics Changes - Gross profit in physical therapy operations increased approximately 21%, while gross profit in injury prevention also rose over 20% [4] - Average visits per clinic per day reached 32.7 in Q4 2025, the highest in the company's history, with a total of 1,560,603 clinic visits recorded in the same quarter [14][17] - IIP income grew by 11.5% in Q4 and 20.2% for the full year of 2025 [16] Market Data and Key Metrics Changes - Despite a 2.9% reduction in Medicare rates throughout 2025, the net rate per patient visit increased by 1% from $104.71 in 2024 to $105.76 in 2025 [16] - The company maintained good control over operating costs, with total physical therapy operating costs down $0.50 per visit in Q4 [16] Company Strategy and Development Direction - The company is focusing on strategic hospital alliances, with expectations of significant contributions to revenue and EBITDA by 2027 [8][25] - Initiatives for 2026 include the rollout of ambient listening documentation support, semi-virtualization of front desk operations, and expansion of cash-based programs [9] - The company aims to enhance efficiency and revenue through AI documentation and remote therapeutic monitoring [48] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about closing the chapter on Medicare rate reductions and highlighted significant opportunities ahead [5][12] - The company anticipates continued growth and improvement in financial results for 2026, with adjusted EBITDA expected to be in the range of $102 million to $106 million [24] Other Important Information - Corporate expenses were 8.5% of net revenue in Q4, consistent with the full year [21] - The company is implementing a new enterprise-wide financial and human resources system, with costs related to this project added back to adjusted EBITDA calculations [21] Q&A Session Summary Question: On strategic alliances and hospital outsourcing - Management confirmed that the $14 million number assumes current volumes and additional facilities are planned [29] Question: Concerns about wage inflation and volume outlook - Management indicated they do not see high pressure on wages and noted a 1.5% increase in visits at mature clinics in Q4 [38][45] Question: Non-Medicare pricing expectations - Management estimated a 1.5%-2% increase for non-Medicare pricing, alongside a 1.75% increase from Medicare [55] Question: Payer mix and workers' compensation - The payer mix remained consistent, with commercial at 48%, Medicare at 33%, and workers' comp at 9.7% [57] Question: Gross margin in injury prevention - Management acknowledged that larger contracts may be margin dilutive initially but are expected to provide profitability in the long run [60] Question: Hospital alliances and outpatient rates - Management clarified that the rates would be hospital outpatient rates and confirmed no profit headwind as they establish these partnerships [78]

Financial Data and Key Metrics Changes - For the year ending 2025, adjusted EBITDA increased by $13.2 million, representing a 16.2% improvement over the prior year [4] - Net revenue increased by 16.3%, with physical therapy operations growing by 16% and injury prevention businesses by 18% [4] - Operating income improved by 18.4% [4] - Adjusted EBITDA for Q4 2025 rose to $24.8 million, up from $21.8 million in Q4 2024, marking a 16.1% increase for the full year [17][22] - GAAP EPS was impacted by the revaluation of non-controlling interest, which can make performance appear worse than it is [22] Business Line Data and Key Metrics Changes - Average visits per clinic per day reached 32.7 in Q4 2025, the highest in the company's history, with a full-year average of 32.2 [14][15] - Total patient visits increased by 11.2% year-over-year, with mature clinics seeing a 1.5% increase in visits [15][38] - Physical Therapy revenues for Q4 2025 were $173.8 million, an increase of $20 million or 13% from the previous year [18] - IIP income grew by 11.5% in Q4 and 20.2% for the full year, with the fourth quarter growth being entirely organic [16][20] Market Data and Key Metrics Changes - The payer mix for Q4 2025 was approximately 48% commercial, 33% Medicare, and 9.7% workers' compensation, with all categories increasing by double digits from Q4 2024 [48] - The net rate per patient visit increased from $104.71 in 2024 to $105.76 in 2025, with Q4 2025 ending at $106.49 [16][18] Company Strategy and Development Direction - The company is focusing on strategic hospital alliances, with expectations of significant contributions to revenue and EBITDA by 2027 [8][24] - Initiatives for 2026 include expanding cash-based programs, remote therapeutic monitoring, and further development in both PT and injury prevention segments [9][12] - The company aims to improve operational efficiency through technology, including AI documentation and semi-virtualization of front desk operations [40] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about closing the chapter on Medicare rate reductions and highlighted significant growth opportunities ahead [5][12] - The company anticipates adjusted EBITDA for 2026 to be in the range of $102 million to $106 million, including contributions from new hospital affiliations [24][25] - Management noted that despite inflationary pressures, they have maintained control over operating costs and expect continued improvement in margins [19][34] Other Important Information - The company incurred approximately $600,000 in implementation costs for a new enterprise-wide financial and human resources system, which is expected to go live on January 1, 2027 [21] - The balance sheet remains strong, with $131 million on a term loan and $35.6 million in cash at the end of the quarter [23] Q&A Session Summary Question: On strategic alliances and hospital partnerships - Management indicated that the $14 million EBITDA contribution assumes current volumes and that there are plans for additional facilities [29][30] Question: Concerns about wage inflation and volume outlook - Management noted a 1.5% increase in visits at mature clinics in Q4 and expressed confidence in controlling wage inflation [34][38] Question: Pricing expectations for non-Medicare services - Management confirmed a reasonable expectation of 1.5%-2% positive pricing for non-Medicare services, alongside a 1.75% increase from Medicare [45][46] Question: Comments on workers' compensation and payer mix - Management reported consistent payer mix and volume for workers' compensation, with all categories increasing by 10%-15% [48] Question: Gross margin in injury prevention - Management acknowledged that while some larger contracts may be margin dilutive initially, they expect profitability to improve as operations scale [50][51] Question: M&A preferences between segments - Management expressed a balanced approach to M&A, with a focus on both PT and injury prevention, while noting the organic growth potential in injury prevention [76][78]

Financial Data and Key Metrics Changes - For the year ending 2025, adjusted EBITDA increased by $13.2 million, representing a 16.2% improvement over the prior year [4] - Net revenue increased by 16.3%, with physical therapy business growing by 16% and injury prevention business by 18% [4] - Operating income improved by 18.4% [4] - Adjusted EBITDA for Q4 2025 was $24.8 million, up from $21.8 million in Q4 2024, marking a $3 million increase [16][21] - Full-year adjusted EBITDA increased by 16.1% from $81.8 million in 2024 to $95 million in 2025 [21] Business Line Data and Key Metrics Changes - Gross profit in physical therapy operations increased approximately 21%, while gross profit in injury prevention also rose over 20% [4] - Physical therapy revenues for Q4 2025 were $173.8 million, an increase of $20 million or 13% from the previous year [17] - IIP income grew by 11.5% in Q4 and 20.2% for the full year of 2025 [15] - The average visits per clinic per day reached 32.7 in Q4, the highest in the company's history [12] Market Data and Key Metrics Changes - Total patient visits increased by 11.2% year-over-year, with a 1.5% increase in visits at mature clinics [13] - The net rate per patient visit increased by 1% from $104.71 in 2024 to $105.76 in 2025, with Q4 ending at $106.49 [14] - The payer mix remained stable, with commercial at just above 48%, Medicare at about 33%, and workers' comp at 9.7% [55] Company Strategy and Development Direction - The company is focusing on strategic hospital alliances, which are expected to contribute at least $14 million in EBITDA by 2027 [7][25] - Initiatives for 2026 include continued rollout of ambient listening documentation support, cash-based program expansion, and remote therapeutic monitoring [8] - The company aims to enhance efficiency through virtualization at the front desk and AI documentation [48] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about closing the chapter on Medicare rate reductions and highlighted significant opportunities ahead [5] - The company anticipates adjusted EBITDA for 2026 to be in the range of $102 million to $106 million, including a $2.5 million revenue increase from the Medicare rate hike [23] - Management noted that they do not foresee significant wage inflation pressures and expect to maintain control over operating costs [37] Other Important Information - The company incurred about $600,000 in implementation costs related to a new enterprise-wide financial and human resources system [20] - GAAP EPS was affected by the revaluation of non-controlling interest, which does not reflect the company's net income [21] Q&A Session Summary Question: What is driving the motivation from hospitals for strategic alliances? - The motivation includes broader patient reach and improved musculoskeletal product lines [28][31] Question: What is the outlook for physical therapy volumes and wage inflation? - The company expects to control wage inflation and noted a 1.5% increase in visits at mature clinics in Q4 [36][43] Question: What is the expected contribution from hospital alliances? - The contribution is based on current volumes, with additional facilities planned [29] Question: What is the expected pricing increase for non-Medicare services? - A 1.5%-2% increase is reasonable for non-Medicare pricing, alongside a 1.75% increase from Medicare [52] Question: What is the gross margin outlook for injury prevention? - Recent large contracts may be margin dilutive initially, but they are expected to provide profitability in the long run [58] Question: How should we think about same-store revenue growth for 2026? - The company expects a combined increase of around 3% in visits and rates for same-store revenues [67]

Core Insights - U.S. Physical Therapy, Inc. reported strong financial results for the fourth quarter and full year ended December 31, 2025, with significant revenue and profit growth compared to the previous year [1][4]. Financial Highlights - Adjusted EBITDA for the year ended December 31, 2025, was $95.0 million, an increase of $13.2 million or 16.2% from $81.8 million in 2024 [3][31]. - Net income attributable to USPH shareholders for 2025 was $39.6 million, compared to $31.4 million in 2024, while earnings per share decreased to $1.42 from $1.84 due to changes in fair value of redeemable noncontrolling interests [3][31][21]. - Operating Results for 2025 was $40.0 million, up from $36.9 million in 2024, translating to $2.63 per share compared to $2.45 per share in the prior year [3][31]. Quarterly Performance - For the fourth quarter of 2025, Adjusted EBITDA was $24.8 million, a 13.5% increase from $21.8 million in the fourth quarter of 2024 [3][22]. - Net income for the fourth quarter of 2025 was $4.2 million, down from $9.2 million in the same quarter of 2024, primarily due to a net loss related to contingent earnout consideration [3][21]. - Net revenue from physical therapy operations in the fourth quarter increased by $20.0 million, or 13.0%, to $173.8 million from $153.8 million in the fourth quarter of 2024 [3][8]. Operational Metrics - Total patient visits for the fourth quarter of 2025 were 1,593,336, an 11.2% increase from 1,432,801 in the fourth quarter of 2024 [3][8]. - The average daily patient visits per clinic reached a record high of 32.7 in the fourth quarter of 2025, compared to 31.6 in the fourth quarter of 2024 [3][8]. - Industrial injury prevention services revenue for the fourth quarter was $28.9 million, an increase of 8.7% compared to $26.6 million in the fourth quarter of 2024 [3][12]. Strategic Developments - The company added 11 clinics and closed 10 in the fourth quarter of 2025, bringing the total to 780 clinics as of December 31, 2025 [3][36]. - Recent acquisitions include an eight-clinic practice and an industrial injury prevention business, expected to generate approximately $8.0 million and $7.0 million in annual revenue, respectively [3][37]. - The company announced strategic alliances with hospital systems to integrate outpatient physical therapy clinics into their clinical services networks, expected to enhance revenue and EBITDA contributions [3][39][41]. Dividend and Guidance - The Board of Directors raised the quarterly dividend rate from $0.45 to $0.46 per share, effective immediately [3][44]. - Management expects Adjusted EBITDA for 2026 to be in the range of $102.0 million to $106.0 million, including contributions from new strategic alliances and a Medicare rate increase [3][42].

Core Viewpoint - U.S. Physical Therapy, Inc. will report its financial results for Q4 and the full year of 2025 on February 25, 2026, after market close, with a conference call scheduled for the following morning [1] Financial Reporting - The financial results will cover the fourth quarter and the entire year ending December 31, 2025 [1] - The announcement of the results will occur after the stock market closes on February 25, 2026 [1] - A conference call to discuss the results will take place on February 26, 2026 [1]

Core Insights - U.S. Physical Therapy, Inc. is a national operator of outpatient physical therapy clinics and provides industrial injury prevention services [1] - The company was founded in 1990 and currently owns and/or manages 780 outpatient physical therapy clinics [1] Company Presentation - Chris Reading, the Chief Executive Officer, presented at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026 [1]

Core Insights - 4D Advisors has initiated a new position in U.S. Physical Therapy by acquiring 110,000 shares valued at $9.34 million as of September 30, 2025, indicating strong confidence in the company despite recent stock price declines [2][11]. Company Overview - U.S. Physical Therapy operates 591 clinics across 39 states, providing outpatient physical therapy and industrial injury prevention services, which include rehabilitation and ergonomic assessments [7][10]. - The company reported trailing twelve months (TTM) revenue of $758.71 million and net income of $36.02 million, with a dividend yield of 2.5% [5][10]. Financial Performance - As of November 14, 2025, U.S. Physical Therapy's stock price was $71.67, reflecting an 18.75% decline over the past year, underperforming the S&P 500 by 32.75 percentage points [3][12]. - Revenue for the first three quarters of 2025 reached $578.3 million, up from $490.9 million in 2024, indicating growth in sales [12]. Investment Position - The new position in U.S. Physical Therapy represents 4.97% of 4D Advisors' 13F reportable assets under management, making it the third largest holding in the fund [3][11]. - The price-to-earnings ratio for U.S. Physical Therapy has decreased from over 85 in Q3 of the previous year to approximately 32 in 2025, suggesting a potentially attractive valuation for investors [13].